Oropharyngeal administration of colostrum for preventing necrotizing enterocolitis and late-onset sepsis in preterm infants with gestational age ≤ 32 weeks: a pilot single-center randomized…

Oropharyngeal administration of colostrum for preventing necrotizing enterocolitis and late-onset sepsis in preterm infants with gestational age 32 weeks: a pilot single-center randomized controlled trial #NeoPapers #neoTwitter https://t.co/SeIgUsXqdq

Oropharyngeal administration of colostrum for preventing necrotizing enterocolitis and late-onset sepsis in preterm infants with gestational age 32 weeks: a pilot single-center randomized controlled trial #NeoPapers #neoTwitter https://t.co/hhP5L0Nw9y

Oropharyngeal administration of colostrum for preventing necrotizing enterocolitis and late-onset sepsis in preterm infants with gestational age 32 weeks: a pilot single-center randomized controlled trial #NeoPapers #neoTwitter https://t.co/4EOcYuKZCx

Oropharyngeal administration of colostrum for preventing necrotizing enterocolitis and late-onset sepsis in preterm infants with gestational age 32 weeks: a pilot single-center randomized controlled trial #NeoPapers #neoTwitter https://t.co/WQsRhavs78